A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors
Clinical trial NCT00743067 · COMPLETED
Trial details
- NCT number
- NCT00743067
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-09
- Primary completion
- 2009-05-02
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.